Clinical Trial Update: Pharmacokinetics of Tenofovir and Tenofovir-diphosphate, Emtricitabine and Emtricitabine-triphosphate, and Rilpivirine Once Daily Over 14 Days Following Drug Intake Cessation in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study in healthy volunteers assessing the disposition of tenofovir and tenofovir-diphosphate, emtricitabine and emtricitabine-triphospha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• Edurant (rilpivirine) (rilpivirine)
• Emtricitabine triphosphate (emtricitabine triphosphate)
• Emtriva (emtricitabine) (emtricitabine)
• Viread (Tenofovir disoproxil fumarate) (Tenofovir disoproxil fumarate)

Snippet

Sponsor: St Stephens Aids Trust | Conditions: HIV | Phase 1 | Status: COMPLETED